
    
      The control of mild-moderate persistent asthma include the need of concomitant medication, as
      inhaled corticosteroids. However, compliance in perennial asthma is low. The aim of this
      study is to assess the possibility to reduce the need of concomitant medication through a
      short-course of subcutaneous immunotherapy.
    
  